Exhibit 99.1

 

Picture 1

303 International Circle       P: 410.427.1700

Suite 200                                F: 410.427.8800

Hunt Valley, MD 21030

 

 

PRESS RELEASE – FOR IMMEDIATE RELEASE

OMEGA ANNOUNCES FOURTH QUARTER 2019 FINANCIAL RESULTS

Completed $896 Million in New Investments in Q4

Increased Quarterly Dividend by $0.01 to $0.67 in October

Provides 2020 Net Income and AFFO Guidance

 

HUNT VALLEY, MARYLAND – February 5, 2020

– Omega Healthcare Investors, Inc. (NYSE:OHI) (the “Company” or “Omega”) today announced its results of operations for the quarter ended December 31, 2019.  The Company reported net income of $61.1 million or $0.27 per common share. The Company also reported NAREIT Funds From Operations (“NAREIT FFO”) for the quarter of $175.5 million or $0.77 per common share, Adjusted Funds From Operations (“AFFO” or “Adjusted FFO”) of $178.3 million or $0.78 per common share, and Funds Available For Distribution (“FAD”) of $163.7 million.

NAREIT FFO, AFFO and FAD are supplemental non-GAAP financial measures that we believe are useful in evaluating the performance of real estate investment trusts.  For more information regarding these non-GAAP measures, see the “Funds From Operations” schedule below and the Company’s website at www.omegahealthcare.com.

 

GAAP NET INCOME

 

For the quarter ended December 31, 2019, the Company reported net income of $61.1 million, or $0.27 per common share, on revenues of $246.7 million.  This compares to net income of $64.9 million, or $0.31 per common share, on revenues of $219.8 million, for the same period in 2018.  The $3.8 million decrease is primarily due to an increase in impairments on real estate properties and a decrease in gains on assets sold.  The decrease was primarily offset by incremental revenue from new investments completed in 2019.

For the year ended December 31, 2019, the Company reported net income of $351.9 million, or $1.58 per common share, on revenues of $928.8 million.  This compares to net income of $293.9 million, or $1.40 per common share, on revenues of $881.7 million, for the same period in 2018.

The year-to-date increase in net income compared to the prior year was primarily due to (i) $45.4 million in revenue from incremental new investments, (ii) a  $30.9 million increase in gains on the sale of assets, (iii) a $10.6 million increase in net income from unconsolidated joint ventures related to gains on the sale of assets  in Q2 2019 and (iv) a $3.8 million decrease in impairments on direct financing leases and real estate properties. The increase in net income was partially offset by (i) a  $20.4 million increase in depreciation and amortization expense related to new investments, (ii) $6.7 million in increased interest expense, (iii) a $4.4 million increase in impairments for uncollectible accounts and (iv) $4.7 million of merger costs related to the May 2019 acquisition of MedEquities Realty Trust, Inc. (“MedEquities”).

 

CEO COMMENTS

 

Taylor Pickett, Omega’s Chief Executive Officer, stated, The fourth quarter represented a strong conclusion to a very productive year.  In December, we completed our acquisition of a 49% interest in a U.K. senior

housing joint venture for approximately $90 million.  In addition, we continue to source smaller, attractively priced acquisitions and new development projects with our existing tenants, while opportunistically divesting of certain non-core holdings.”

 

Mr. Pickett continued, “In 2019, we were able to accretively invest over $1.6 billion, furthering our relationship with quality existing tenants while selectively diversifying our operator base by leasing to additional proven and experienced operators.”

 

Mr. Pickett concluded, “We expect the momentum of 2019 to carry into 2020.  We are excited for our Maplewood-run Carnegie Hill assisted living facility to begin accepting residents in the coming months.  The new Medicare reimbursement model, the Patient Driven Payment Model or PDPM, has received positive feedback from operators. While it’s too early to make any definitive conclusions, when combined with the recent 2.4% increase in Medicare reimbursement and the promising demographic tailwinds, we believe our operators are well-positioned to weather the continued labor cost pressures and generate solid financial performance over time.”

 

 

2020 RECENT DEVELOPMENTS AND FOURTH QUARTER HIGHLIGHTS

 

In Q1 2020, the Company

 

·

declared a $0.67 per share quarterly common stock dividend.

 

In Q4 2019, the Company

 

·

completed the $735 million Encore portfolio acquisition.

·

acquired a 49% interest in a U.K. senior housing joint venture for $93 million from Healthpeak.

·

settled its 7.5 million common shares forward sale agreement executed in September, generating $296 million in net proceeds.

·

sold 11 facilities for $33 million in cash proceeds generating $3 million in gains.

·

invested $57 million in capital renovation and construction-in-progress projects.

·

paid a $0.67 per share quarterly common stock dividend, representing a $0.01 increase over Q3 2019.

 

In Q3 2019, the Company

 

·

issued $500 million aggregate principal amount of 3.625% Senior Notes due 2029.

·

priced a public offering to sell 7.5 million common shares on a forward basis.

·

sold 19 facilities for $177 million in cash proceeds generating $53 million in gains.

·

completed $33 million of new investments.

·

invested $38 million in capital renovation and construction-in-progress projects.

·

paid a $0.66 per share quarterly common stock dividend.

 

In Q2 2019, the Company

 

·

completed the $623 million acquisition by merger of MedEquities.

·

invested $55 million in capital renovation and construction-in-progress projects.

·

paid a $0.66 per share quarterly common stock dividend.

 

In Q1 2019, the Company

 

·

entered into a definitive merger agreement to acquire MedEquities.

·

finalized the Orianna portfolio restructuring.

·

invested $42 million in capital renovation and construction-in-progress projects.

·

paid a $0.66 per share quarterly common stock dividend.

 

FOURTH QUARTER 2019 RESULTS

 

Operating Revenues and Expenses – Revenues for the quarter ended December 31, 2019 totaled $246.7 million, which included $14.1 million of non-cash revenue, $2.4 million of real estate tax and ground rents, $1.4 million of one-time revenue and a write-off of $0.2 million in uncollectible accounts primarily related to straight-line revenue.

Expenses for the quarter ended December 31, 2019 totaled $133.7 million, consisting of $80.5 million of depreciation and amortization expense, $9.9 million of general and administrative (“G&A”) expense, $3.4 million of real estate tax and ground lease expense, $35.7 million of impairment on real estate properties, $3.8 million of stock-based compensation expense and $0.2 million of impairment on direct financing leases.

Other Income and Expense – Other income and expense for the quarter ended December 31, 2019 was a net expense of $54.8 million, primarily consisting of $52.8 million of interest expense and $2.8 million of amortized deferred financing costs.

Funds From Operations – For the quarter ended December 31, 2019, NAREIT FFO was $175.5 million, or $0.77 per common share, on 228 million weighted-average common shares outstanding, compared to $124.7 million, or $0.59 per common share on 212 million weighted-average common shares outstanding, for the same period in 2018.

The $175.5 million of NAREIT FFO for the quarter ended December 31, 2019 includes $3.8 million of non-cash stock-based compensation expense, $0.2 million write-off of non-cash revenue (primarily straight-line revenue) and $0.2 million of impairment on direct financing leases offset by $1.4 million of one-time revenue.

The $124.7 million of NAREIT FFO for the quarter ended December 31, 2018 includes $27.2 million of impairments on direct financing leases, $3.9 million of non-cash stock-based compensation expense, $0.4 million of merger related costs and $0.3 million in provisions for uncollectable accounts offset by $1.1 million in one-time non-cash revenue.

 

Adjusted FFO was $178.3 million, or $0.78 per common share, for the quarter ended December 31, 2019, compared to $155.3 million, or $0.73 per common share, for the same quarter in 2018.  For further information see the “Funds From Operations” schedule below and the Company’s website.

2019 ANNUAL RESULTS

 

Revenues and Expenses – Revenues for the year ended December 31, 2019 totaled $928.8 million, which included $60.9 million of non-cash revenue, $12.9 million of real estate tax and ground rents, $2.4 million of one-time revenue and a write-off of $11.1 million in uncollectible accounts primarily related to straight-line revenue.

Expenses for the year ended December 31, 2019 totaled $432.8 million, consisting of $301.7 million of depreciation and amortization expense, $45.3 million of impairment on real estate properties, $41.8 million of G&A expense, $16.1 million of real estate tax and ground lease expense, $14.9 million of stock-based compensation expense, $7.9 million of impairment on direct financing leases and $5.1 million of merger costs related to the May 2019 acquisition of MedEquities.

Other Income and Expense – Other income and expense for the year ended December 31, 2019 was a net expense of $207.9 million, primarily consisting of $199.2 million of interest expense and $9.6 million of amortized deferred financing costs.

Funds From Operations – For the year ended December 31, 2019, NAREIT FFO was $640.0 million, or $2.88 per common share, on 222 million weighted-average common shares outstanding, compared to $587.2 million, or $2.80 per common share on 210 million weighted-average common shares outstanding, for the same period in 2018.

The $640.0 million of NAREIT FFO for the year ended December 31, 2019 includes $14.9 million of non-cash stock-based compensation expense, $11.1 million write-off of non-cash revenue (primarily straight-line revenue), $7.9 million of impairments on direct financing leases, $5.1 million of merger costs related to the May 2019 acquisition of MedEquities, $2.0 million of interest refinancing cost related to an unconsolidated joint venture, $1.7 million of restructuring costs and a $1.1 million one-time lease termination payment offset by $2.4 million of one-time revenue.

The $587.2 million of NAREIT FFO for the year ended December 31, 2018 includes $27.2 million of impairments on direct financing leases, $16.0 million of non-cash stock-based compensation expense, $6.7 million in provisions for uncollectable accounts, $2.0 million purchase option buyout and $0.4 million of merger costs related to the May 2019 acquisition of MedEquities offset by $1.1 million of one-time revenue.

 

Adjusted FFO was $681.4 million, or $3.07 per common share, for the year ended December 31, 2019, compared to $638.3 million, or $3.04 per common share, for 2018.  For further information see the “Funds From Operations” schedule below and the Company’s website.

FINANCING ACTIVITIES

 

7.5 Million Share Forward Stock Offering – On September 9, 2019, in connection with a $300 million underwritten public offering, the Company entered into a forward equity sales agreement to sell 7.5 million shares of its common stock at an initial net price of $40.01 per share, after underwriting discounts and commissions.  On December 27, 2019, the Company settled the forward equity sales agreement by the physical delivery of 7.5 million shares of common stock in exchange for $295.9 million of net cash proceeds.

 

Equity Shelf Program and Dividend Reinvestment and Common Stock Purchase Plan – During the quarter ended December 31, 2019, the Company sold 0.6 million shares of its common stock, generating $25.6 million of gross proceeds under its Equity Shelf Program and its Dividend Reinvestment and Common Stock Purchase Plan:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

Equity Shelf (At-the-Market) Program for 2019

 

 

 

(in thousands, except price per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Q1

 

Q2

 

Q3

 

Q4

 

 

Year To Date

Number of shares

 

 

2,221

 

 

733

 

 

124

 

 

55

 

 

 

3,133

Average price per share

 

$

35.26

 

$

36.81

 

$

36.54

 

$

42.30

 

 

$

35.80

Gross proceeds

 

$

78,325

 

$

26,993

 

$

4,498

 

$

2,347

 

 

$

112,163

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

Dividend Reinvestment and Common Stock Purchase Plan for 2019

 

 

 

(in thousands, except price per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Q1

 

Q2

 

Q3

 

Q4

 

 

Year To Date

Number of shares

 

 

892

 

 

589

 

 

997

 

 

568

 

 

 

3,046

Average price per share

 

$

36.19

 

$

37.02

 

$

37.87

 

$

40.84

 

 

$

37.77

Gross proceeds

 

$

32,286

 

$

21,817

 

$

37,742

 

$

23,206

 

 

$

115,051

 

2019 FOURTH QUARTER PORTFOLIO ACTIVITY

 

Q4 Portfolio Activity:

 

$896 Million of New Investments in Q4 2019 – In the fourth quarter of 2019, the Company completed approximately $839 million of new investments and $57 million in capital renovations and new construction projects consisting of the following:

 

$735 Million Encore Portfolio Acquisition – On October 31, 2019, the Company completed its previously announced 60 facility acquisition for $735 million.  Consideration consisted of approximately $346 million in cash and the assumption of approximately $389 million in mortgage loans guaranteed by the U.S. Department of Housing and Urban Development (“HUD”).  The HUD loans have a blended “all-in” rate (interest rates and mortgage insurance premiums) of 3.66% per annum with maturities between September 2046 and January 2052.

 

The 60 facilities, consisting of 58 skilled nursing facilities (“SNFs”) and two assisted living facilities (“ALFs”) representing 6,590 operating beds are located in Florida (37), North Carolina (8), Mississippi (6), Louisiana (4), Idaho (2), Kentucky (1), Missouri (1) and Montana (1).  These facilities are leased to two operators within three triple net leases providing for approximately $64 million in 2020 annual contractual cash rent.

 

$93 Million Joint VentureOn December 18, 2019, the Company purchased from Healthpeak Properties, Inc. its 49% interest in a U.K. portfolio consisting of 67 senior housing facilities, as well as related development and working capital loans, for an aggregate purchase price of approximately $93 million before transaction costs.

 

$57 Million of New InvestmentsIn the fourth quarter of 2019, the Company invested $56.9 million under its capital renovation and construction-in-progress programs.

 

Asset Sales and Impairments:

 

$33 Million in Assets Sales – In the fourth quarter of 2019, the Company sold 11 properties for $33.3 million in cash, recognizing a gain of approximately $2.9 million.

 

Impairments and Assets Held for Sale – During the fourth quarter of 2019, the Company recorded an impairment charge of $35.7 million to reduce the net book values on 17 properties to their estimated fair values or expected selling prices.

 

As of December 31, 2019, the Company had six properties classified as assets held for sale totaling approximately $4.9 million.  The Company expects to sell these properties over the next few quarters.

 

DIVIDENDS

 

On January 15, 2019, the Board of Directors declared a common stock dividend of $0.67 per share, to be paid February 14, 2020 to common stockholders of record as of the close of business on January 31, 2020.

 

TAX TREATMENT FOR 2019 DIVIDENDS

 

On February 15, 2019, May 15, 2019, August 15, 2019 and November 15, 2019, the Company paid dividends to its common stockholders in the per share amounts of $0.66, $0.66, $0.66 and $0.67 for stockholders of record on January 31, 2019, April 30, 2019, July 31, 2019 and October 31, 2019, respectively. The Company has determined the tax treatment for the dividends is as follows:

 

 

 

 

 

 

 

 

 

Dividend Payment Date

    

% Taxable as Ordinary Income

 

% Taxable as Return of Capital

 

% Taxable as Capital Gain

February 15, 2019

 

66.5028%

 

22.3133%

 

11.1839%

May 15, 2019

 

66.5029%

 

22.3133%

 

11.1838%

August 15, 2019

 

66.5029%

 

22.3133%

 

11.1838%

November 15, 2019

 

66.5028%

 

22.3133%

 

11.1839%

 

2020 GUIDANCE

 

The Company expects its 2020 annual net income to be between $1.58 and $1.66 per diluted share and its Adjusted FFO to be between $3.12 to $3.20 per diluted share.

 

Bob Stephenson, Omega’s CFO, commented, “Our 2020 guidance reflects the annual impact of $863 million of net 2019 fourth quarter acquisitions and asset sales, revenue from Maplewood related to the Carnegie Hill project, continuing Daybreak on a cash basis and the full impact of our 2019 capital markets activity.”  Mr. Stephenson continued, “The $296 million in net proceeds from the physical settlement of our 7.5 million common shares equity forward agreement on December 27th adds additional capacity to our credit facility for potential acquisitions.”

 

The following table presents a reconciliation of Omega’s guidance regarding Adjusted FFO to projected GAAP earnings.

 

 

 

 

 

    

 

 

 

2020 Annual 

 

 

Guidance Range

 

 

(per diluted common

 

 

share)

Net Income

 

$1.58- $1.66

Depreciation

 

1.42

Depreciation – unconsolidated joint venture

 

0.05

Gain on assets sold – net

 

-

NAREIT FFO

 

$3.05 - $3.13

Adjustments:

 

 

Stock-based compensation expense

 

0.07

Adjusted FFO

 

$3.12 - $3.20

Note: All per share numbers rounded to 2 decimals.

 

The Company's Adjusted FFO guidance for 2020 includes (i) the annual impact of acquisitions completed in 2019, (ii) approximately $21 million of cash rent payments from Maplewood related to the Carnegie Hill project, (iii) over $82 million of planned capital renovation projects with 2020 estimated in-service dates or spending that we expect to generate cash in 2020, (iv) Daybreak continuing on a cash basis, (v) approximately $9.5 million to $10.5 million of quarterly G&A, and (vi) approximately $25 million to $35 million of quarterly equity issuances.  It excludes additional acquisitions and asset sales, the impact of gains and losses from the sale of assets, certain revenue and expense items, interest refinancing expense, additional capital transactions, acquisition costs, and additional provisions for uncollectible accounts, if any.

The Company's guidance is based on several assumptions, which are subject to change and many of which are outside the Company’s control.  If actual results vary from these assumptions, the Company's expectations may change.  Without limiting the generality of the foregoing, the timing of collection of rental obligations from operators on a cash basis, the timing and completion of acquisitions, divestitures, capital and financing transactions, and variations in stock-based compensation expense may cause actual results to vary materially from our current expectations. There can be no assurance that the Company will achieve its projected results.  The Company may, from time to time, update its publicly announced Adjusted FFO guidance, but it is not obligated to do so.

 

CONFERENCE CALL

The Company will be conducting a conference call on Thursday, February 6, 2020 at 10 a.m. Eastern to review the Company’s 2019 fourth quarter results and current developments.  Analysts and investors within the United States interested in participating are invited to call (877) 511-2891.  The Canadian toll-free dial-in number is (855) 669-9657.  All other international participants may use the dial-in number (412) 902-4140.  Ask the operator to be connected to the “Omega Healthcare’s Fourth Quarter 2019 Earnings Call.”

To listen to the conference call via webcast, log on to www.omegahealthcare.com and click the “earnings call” icon on the Company’s home page.  Webcast replays of the call will be available on the Company’s website for two weeks following the call.

*   *   *   *   *   *

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities.  Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure.  The assets span all regions within the US, as well as in the UK.

 

FOR FURTHER INFORMATION, CONTACT

Matthew Gourmand, SVP, Investor Relations

or

Bob Stephenson, CFO at (410) 427-1700


The following information was filed by Ohi Healthcare Properties Limited Partnership on Wednesday, February 5, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Ohi Healthcare Properties Limited Partnership's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ohi Healthcare Properties Limited Partnership.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account